Merck’s Emerging Markets R&D Head RuiPing Dong On Developing Drugs To Meet Local Needs: An Interview With PharmAsia News (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
Merck discusses its R&D strategy in emerging markets; the company announced last week the largest ever R&D investment in China for a pharmaceutical company.